REPRESENT-PF Registry
NCT: NCT07535268 · RECRUITING
NCT IDNCT07535268
StatusRECRUITING
Start Date2026-03-30
Completion2028-03-01
Brief Summary
This pragmatic, prospective, single-arm, multi-center, observational registry will evaluate the safety and effectiveness of PFA for the treatment of atrial fibrillation in underrepresented minority patients using FDA approved Boston Scientific PFA catheters; all data collected will be standard of care.
Frequently Asked Questions
What is REPRESENT-PF Registry?
REPRESENT-PF Registry is a clinical trial registered under NCT07535268. Current status: RECRUITING.
What is the status of NCT07535268?
The current status of NCT07535268 (REPRESENT-PF Registry) is: RECRUITING.
When did REPRESENT-PF Registry start?
REPRESENT-PF Registry started on 2026-03-30.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.